Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503850 | 0.79 | KDM4E (0.31) | KDM4ETSHRTDP1 | |
| SCHEMBL18759556 | 0.78 | — | — | |
| SCHEMBL18759557 | 0.78 | — | — | |
| SCHEMBL501614 | 0.75 | KDM4E (0.32) | KDM4ETSHRTDP1 | |
| SCHEMBL811372 | 0.74 | KDM4E (0.33) | KDM4ETSHRTDP1 | |
| SCHEMBL23629336 | 0.71 | KDM4E (0.30) | KDM4ETSHRTDP1 | |
| SCHEMBL250574 | 0.71 | KDM4E (0.30) | KDM4ETSHRTDP1 | |
| SCHEMBL191216 | 0.71 | KDM4E (0.30) | KDM4ETSHRTDP1 | |
| SCHEMBL3937477 | 0.71 | KDM4E (0.30) | KDM4ETSHRTDP1 | |
| SCHEMBL23002418 | 0.71 | KDM4E (0.34) | KDM4ETSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090098410-A1 | Trimethine Dimer Compound and Optical Recording Medium Using the Same | MITSUI CHEMICALS, INC. (JP) | 2009-04-16 | — | — | US | disclosed |
| EP-1900779-A1 | TRIMETHINE DIMER COMPOUND AND OPTICAL RECORDING MEDIUM USING SAME | Mitsui Chemicals, Inc. (JP) | 2008-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098410-A1 | Trimethine Dimer Compound and Optical Recording Medium Using the Same | TXNL1, TMCO1, TFPI2 | KDM4E 3379/4885TSHR 1535/4885TDP1 240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.